Cowealth Medical China Co Ltd. Stock Analysis 603122.SS

Cowealth Medical China Co., Ltd. is a channel provider in the medical circulation field. The company is headquartered in Shanghai, Shanghai and currently employs 161 full-time employees. The company went IPO on 2022-02-16. The Company’s business includes in-vitro diagnostic product consolidation, medical product distribution, and hospital empowerment services. The in-vitro diagnostic product consolidation business involves the wholesale of in-vitro diagnostic products, primarily including immunodiagnostics, biochemical diagnostics, clinical testing, point-of-care testing, molecular diagnostics, pathology, and microbiological testing. The medical product distribution business mainly engages in the wholesale and retail of equipment in the fields of radiotherapy, immunodiagnostics, and biochemical diagnostics. Hospital empowerment services primarily include the development of hospital department operation management software and the provision of guidance services for hospital department operation management. The firm primarily operates in the domestic market.